Abstract: Method for treating pancreatic cancer using des-methyl pateamine A (DMPatA) or a pharmaceutically acceptable salt thereof, or des-methyl des-amino pateamine A (DMDAPatA) or a pharmaceutically acceptable salt thereof.
Type:
Application
Filed:
April 4, 2024
Publication date:
October 10, 2024
Applicants:
Baylor University, The Trustees of Columbia University in the City of New York
Inventors:
Daniel Romo, Kenneth G. Hull, Haoran Xue, Mingzhao Zhu, Susan E. Bates, Maryam Safari, Antonio Fojo
Abstract: Disclosed are compositions, devices, kits, and methods for treatment of Enterobacteriaceae infection. Aspects of the present disclosure are directed to bacteriophage compositions comprising one or more of ES17, ES19, HP3, HP3.1, and HP3.2. Certain aspects of the disclosure are directed to compositions comprising (a) bacteriophage ES17 or bacteriophage ES19, (b) bacteriophage HP3, and (c) bacteriophage HP3.1. Also disclosed are compositions comprising bacteriophage HP 3.2. Further disclosed are devices and kits comprising such compositions and methods for use of such compositions in treatment and prevention of pathogenic E. coli infection.
Type:
Application
Filed:
June 24, 2024
Publication date:
October 10, 2024
Applicants:
Baylor College of Medicine, United States Government as Represented by the Department of Veterans Affairs
Inventors:
Anthony Maresso, Robert Ramig, Sabrina Green, Austen Terwilliger, Keiko Salazar, Justin R. Clark, Barbara Trautner
Abstract: Systems and methods for a multi-primary color system for display. A multi-primary color system increases the number of primary colors available in a color system and color system equipment. Increasing the number of primary colors reduces metameric errors from viewer to viewer. One embodiment of the multi-primary color system includes Red, Green, Blue, Cyan, Yellow, and Magenta primaries. The systems of the present invention maintain compatibility with existing color systems and equipment and provide systems for backwards compatibility with older color systems.
Type:
Application
Filed:
June 19, 2024
Publication date:
October 10, 2024
Applicant:
Baylor University
Inventors:
James M. DeFilippis, Mitchell J. Bogdanowicz
Abstract: Disclosed herein are methods and compositions for modulating immune responses by using decoy molecules to bind to soluble or other ligands. In specific embodiments, the decoy molecules comprise a domain that binds to a target immunosuppressive ligand and another domain that releases immunostimulatory signals when activated. In specific embodiments, the decoy molecules are soluble and are secreted by transgenic T cells at a tumor site, such as upon antigen engagement, and they protect the transgenic cells themselves and also bystander (e.g., non-modified) endogenous immune cells.
Type:
Application
Filed:
August 12, 2022
Publication date:
October 10, 2024
Applicant:
Baylor College of Medicine
Inventors:
Pradip Bajgain, Juan Fernando Vera Valdes, Ann Marie Leen, Mohsen Basiri
Abstract: Embodiments of the disclosure include methods and compositions in which adoptive T cell therapy is generated by particular methods in which a population of the T cells are directed against one or more neoantigens of any kind. In specific embodiments, the T cells are produced following exposure of PBMCs to peptides that encompass one or more antigens, and the produced T cells are tested for their efficacy. Following identification of efficacious peptides, they are utilized to produce the adoptive T cell therapy against the neoantigen(s).
Type:
Application
Filed:
October 6, 2022
Publication date:
October 3, 2024
Applicant:
Baylor College of Medicine
Inventors:
Ann Marie Leen, Wingchi Leung, Premal Lulla
Abstract: This disclosure addresses burdensome pulmonary aspirations and proposes a non-invasive system and device capable of detecting gastric distension as a predictive “warning sign” of aspiration risk and a treatable risk factor to reduce the risk of highly morbid and often lethal aspiration events.
Abstract: Embodiments of the disclosure include methods and compositions for producing NKT cells effective for immunotherapy and also methods and compositions for providing an effective amount of NKT cells to an individual in need of immunotherapy. In specific embodiments, the NKT cells are CD62L+ and have been exposed to one or more costimulatory agents to maintain CD62L expression. The NKT cells may be modified to incorporate a chimeric antigen receptor, in some cases.
Type:
Application
Filed:
June 12, 2024
Publication date:
October 3, 2024
Applicant:
Baylor College of Medicine
Inventors:
Leonid S. Metelitsa, Amy N. Courtney, Gengwen Tian
Abstract: Embodiments of the disclosure include methods and compositions for enhancing expansion of immune cells for immunotherapy. In particular embodiments, immune cells, such as T-cells, express a constitutively active cytokine receptor in which the transmembrane and endodomains are able to provide an activating signal separately from any input to the corresponding exodomain to which they are operably linked. In specific embodiments, the transmembrane and endodomain from IL-7R? is utilized with the exodomain of CD34.
Type:
Grant
Filed:
August 11, 2017
Date of Patent:
October 1, 2024
Assignee:
Baylor College of Medicine
Inventors:
Thomas C. T. Shum, Stephen M. G. Gottschalk, Bilal Omer, Cliona M. Rooney
Abstract: An automatic insertion device and method of using the same is provided. A vibrator and an extender are connected to a penetrating member and are both in electrical communication with a controller. A detector identifies a subcutaneous target for insertion and the insertion angle, distance and trajectory for the penetrating member are calculated. The vibrator provides vibrations to the penetrating member and the extender advances the penetrating member for insertion. The vibrator and extender are in electrical communication with one another during the insertion process and adjustments to the insertion speed are made based on feedback of vibrational load encountered by the vibrator during insertion, and adjustments to the vibrations are made based on feedback of insertion load encountered by the extender during insertion. Iterative samples are taken to constantly adjust the operation of one motor based on the operations and feedback from the other motor.
Type:
Application
Filed:
October 24, 2023
Publication date:
September 26, 2024
Applicants:
Obvius Robotics, Inc., Baylor College Of Medicine
Inventors:
Roger B. Bagwell, Ryan S. Clement, Maureen L. Mulvihill, Casey A. Scruggs, Kevin A. Snook, William E. Cohn, James Patrick Herlihy, Kenneth Wayne Rennicks
Abstract: The present invention includes systems and methods for a multi-primary color system for display. A multi-primary color system increases the number of primary colors available in a color system and color system equipment. Increasing the number of primary colors reduces metameric errors from viewer to viewer. One embodiment of the multi-primary color system includes Red, Green, Blue, Cyan, Yellow, and Magenta primaries. The systems of the present invention maintain compatibility with existing color systems and equipment and provide systems for backwards compatibility with older color systems.
Type:
Application
Filed:
May 22, 2024
Publication date:
September 19, 2024
Applicant:
Baylor University
Inventors:
Mitchell J. Bogdanowicz, Corey P. Carbonara, Michael F. Korpi, James M. DeFilippis, Gary B. Mandle
Abstract: Systems and methods for a multi-primary color system for display. A multi-primary color system increases the number of primary colors available in a color system and color system equipment. Increasing the number of primary colors reduces metameric errors from viewer to viewer. One embodiment of the multi-primary color system includes Red, Green, Blue, Cyan, Yellow, and Magenta primaries. The systems of the present invention maintain compatibility with existing color systems and equipment and provide systems for backwards compatibility with older color systems.
Type:
Application
Filed:
May 8, 2024
Publication date:
September 19, 2024
Applicant:
Baylor University
Inventors:
James M. DeFilippis, Mitchell J. Bogdanowicz, Corey P. Carbonara, Michael F. Korpi, Gary B. Mandle
Abstract: The present disclosure provides methods for treating bone diseases, such as bone cancers, bone metastasis of cancers, or osteoporosis, by administering a bone-targeting polypeptide conjugate. The bone-targeting polypeptide conjugate may be a bone-targeting antibody conjugate.
Type:
Application
Filed:
January 19, 2022
Publication date:
September 12, 2024
Applicants:
William Marsh Rice University, Baylor College of Medicine
Abstract: Polypeptides comprising: (i) an MHC class I ? polypeptide association domain, (ii) a transmembrane domain, and (iii) a signalling domain comprising an ITAM-containing sequence are disclosed. Also disclosed are nucleic acids and expression vectors encoding, compositions comprising, and methods using such polypeptides.
Abstract: A secondary borane featuring two ortho-carborane substituents [HBoCb2, oCb=ortho-carborane] is useful as a powerful hydroboration reagent. The Lewis superacid, bis(1-methyl-ortho-carboranyl)borane, is rapidly accessed in two steps. It is a very effective hydroboration reagent capable of the hydroboration of alkenes, alkynes, cyclopropanes, and allenes. The large steric profile prevents double hydroboration of alkynes and promotes regioselectivity in allenes. The compound is a Lewis superacidic secondary borane and effective neutral hydroboration reagent.
Abstract: Provided are methods of inhibiting spreading depolarization in a subject by administering a sigma-1 agonist or a sigma-1 positive modulator to the subject. In some cases the subject is administered fenfluramine as the sigma-1 positive modulator. In some cases, the subject has been diagnosed with epilepsy, traumatic brain injury, migraines, stroke, ischemic attacks, hypoxia or an increased risk of sudden unexpected death in epilepsy (SUDEP), or a combination thereof.
Type:
Application
Filed:
May 14, 2024
Publication date:
September 12, 2024
Applicants:
ZOGENIX INTERNATIONAL LIMITED, BAYLOR COLLEGE OF MEDICINE
Inventors:
Bradley S. GALER, Stephen J. FARR, Thaddeus Cromwell REEDER, Jeffrey L. NOEBELS, Isamu AIBA
Abstract: The present invention includes systems and methods for a multi-primary color system for display. A multi-primary color system increases the number of primary colors available in a color system and color system equipment. Increasing the number of primary colors reduces metameric errors from viewer to viewer. One embodiment of the multi-primary color system includes Red, Green, Blue, Cyan, Yellow, and Magenta primaries. The systems of the present invention maintain compatibility with existing color systems and equipment and provide systems for backwards compatibility with older color systems.
Type:
Application
Filed:
May 1, 2024
Publication date:
August 29, 2024
Applicant:
Baylor University
Inventors:
James M. DeFilippis, Mitchell J. Bogdanowicz, Corey P. Carbonara, Michael F. Korpi, Gary B. Mandle
Abstract: A disclosed radio frequency (RF) system, such as a cognitive radar, includes a software defined radio (SDR), an adaptive transmit amplifier, and a host computer. The system performs optimization operations including selecting an initial impedance as a load impedance for the RF device and iteratively performing image completion operations until a convergence criterion is satisfied. The image completion operations may include measuring a performance of the RF device to obtain a measured performance corresponding to the load impedance, storing the measured performance as a point on a measured load-pull contour image, performing a load-pull extrapolation to extrapolate, from the load impedance, a predicted optimal impedance, and saving the predicted impedance as the load impedance for a next iteration of the image completion operations. The convergence criterion may be satisfied when a predicted impedance matches one of the previously measured impedances.
Abstract: Equipotent indolocarbazole-derived analogs of staurosporine identified herein are prepared through C—H borylation chemistry. Functionality resides at C2 and C10 of the indolocarbazole aromatic region. Introducing functionality in this previously inaccessible region does not abrogate kinase activity and is shown to change the selectivity profile.
Abstract: A method for ultrasonic inspection of fused filament fabrication (FFF) manufactured samples and of carbon fiber reinforced polymer (CFRP) laminates is disclosed that includes performing a time-frequency transforms including the short-time Fourier transform (STFT) and the wavelet synchrosqueezed transform (WSST), inspecting features in FFF manufactured samples for porosity, layer height and missing extrudate and visualizing CFRP laminate wrinkle.
Type:
Application
Filed:
February 16, 2024
Publication date:
August 22, 2024
Applicant:
BAYLOR UNIVERSITY
Inventors:
Luke W. Battershell, David A. Jack, Trevor Fleck
Abstract: The present invention regards methods and/or compositions related to Natural Killer T cells that are engineered to harbor an expression construct that encodes IL-2, IL-4, IL-7, and/or IL-15 and additionally or alternatively comprise a chimeric antigen receptor (CAR).
Type:
Application
Filed:
August 15, 2023
Publication date:
August 22, 2024
Applicant:
Baylor College of Medicine
Inventors:
Leonid S. METELITSA, Daofeng LIU, Gianpietro DOTTI, Andras HECZEY